Annual Operating Expenses
$24.08 M
-$27.97 M-53.74%
December 31, 2023
Summary
- As of February 8, 2025, AVTX annual total operating expenses is $24.08 million, with the most recent change of -$27.97 million (-53.74%) on December 31, 2023.
- During the last 3 years, AVTX annual operating expenses has fallen by -$29.61 million (-55.14%).
- AVTX annual operating expenses is now -72.01% below its all-time high of $86.04 million, reached on December 31, 2021.
Performance
AVTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$13.82 M
+$4.70 M+51.43%
September 30, 2024
Summary
- As of February 8, 2025, AVTX quarterly total operating expenses is $13.82 million, with the most recent change of +$4.70 million (+51.43%) on September 30, 2024.
- Over the past year, AVTX quarterly operating expenses has increased by +$4.70 million (+51.43%).
- AVTX quarterly operating expenses is now -55.37% below its all-time high of $30.98 million, reached on March 31, 2021.
Performance
AVTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
AVTX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -53.7% | +51.4% |
| 3 y3 years | -55.1% | +51.4% |
| 5 y5 years | +29.0% | +180.4% |
AVTX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -72.0% | at low | -35.1% | +269.7% |
| 5 y | 5-year | -72.0% | at low | -55.4% | +269.7% |
| alltime | all time | -72.0% | +118.8% | -55.4% | +743.8% |
Avalo Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $13.82 M(+51.4%) |
| Jun 2024 | - | $9.13 M(+72.0%) |
| Mar 2024 | - | $5.31 M(+16.9%) |
| Dec 2023 | $24.08 M(-53.7%) | $4.54 M(+21.5%) |
| Sep 2023 | - | $3.74 M(-47.2%) |
| Jun 2023 | - | $7.08 M(-18.7%) |
| Mar 2023 | - | $8.72 M(-4.5%) |
| Dec 2022 | $52.06 M(-39.5%) | $9.13 M(-11.6%) |
| Sep 2022 | - | $10.33 M(-8.6%) |
| Jun 2022 | - | $11.29 M(-47.0%) |
| Mar 2022 | - | $21.31 M(+20.0%) |
| Dec 2021 | $86.04 M(+60.2%) | $17.76 M(+5.0%) |
| Sep 2021 | - | $16.91 M(-17.1%) |
| Jun 2021 | - | $20.40 M(-34.1%) |
| Mar 2021 | - | $30.98 M(+74.4%) |
| Dec 2020 | $53.69 M(+117.3%) | $17.76 M(+24.1%) |
| Sep 2020 | - | $14.31 M(+9.5%) |
| Jun 2020 | - | $13.07 M(+52.9%) |
| Mar 2020 | - | $8.55 M(+36.6%) |
| Dec 2019 | $24.71 M | $6.26 M(+26.9%) |
| Sep 2019 | - | $4.93 M(-26.6%) |
| Jun 2019 | - | $6.71 M(-1.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $6.81 M(-417.1%) |
| Dec 2018 | $18.67 M(+40.5%) | -$2.15 M(-134.0%) |
| Sep 2018 | - | $6.31 M(-14.7%) |
| Jun 2018 | - | $7.40 M(+4.1%) |
| Mar 2018 | - | $7.11 M(+19.4%) |
| Dec 2017 | $13.29 M(-22.9%) | $5.95 M(+91.1%) |
| Sep 2017 | - | $3.12 M(+61.2%) |
| Jun 2017 | - | $1.93 M(-15.4%) |
| Mar 2017 | - | $2.28 M(+22.3%) |
| Dec 2016 | $17.23 M(+56.5%) | $1.87 M(-70.3%) |
| Sep 2016 | - | $6.28 M(+51.9%) |
| Jun 2016 | - | $4.14 M(-16.3%) |
| Mar 2016 | - | $4.94 M(+34.5%) |
| Dec 2015 | $11.01 M(-35.7%) | $3.68 M(+87.6%) |
| Sep 2015 | - | $1.96 M(-32.2%) |
| Jun 2015 | - | $2.89 M(+16.4%) |
| Mar 2015 | - | $2.48 M(-35.2%) |
| Dec 2014 | $17.12 M(+32.3%) | $3.83 M(-36.1%) |
| Sep 2014 | - | $6.00 M(+64.1%) |
| Jun 2014 | - | $3.66 M(+0.7%) |
| Mar 2014 | - | $3.63 M |
| Dec 2013 | $12.93 M | - |
FAQ
- What is Avalo Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Avalo Therapeutics?
- What is Avalo Therapeutics annual operating expenses year-on-year change?
- What is Avalo Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Avalo Therapeutics?
- What is Avalo Therapeutics quarterly operating expenses year-on-year change?
What is Avalo Therapeutics annual total operating expenses?
The current annual operating expenses of AVTX is $24.08 M
What is the all time high annual operating expenses for Avalo Therapeutics?
Avalo Therapeutics all-time high annual total operating expenses is $86.04 M
What is Avalo Therapeutics annual operating expenses year-on-year change?
Over the past year, AVTX annual total operating expenses has changed by -$27.97 M (-53.74%)
What is Avalo Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of AVTX is $13.82 M
What is the all time high quarterly operating expenses for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly total operating expenses is $30.98 M
What is Avalo Therapeutics quarterly operating expenses year-on-year change?
Over the past year, AVTX quarterly total operating expenses has changed by +$4.70 M (+51.43%)